Pilot Study of Budesonide for Patients With Primary Sclerosing Cholangitis - Related Studies

Pilot Study of Budesonide for Patients With Primary Sclerosing Cholangitis

This study is ongoing, but not recruiting participants.

Study NCT00004842. Last updated on June 23, 2005. Information provided by Office of Rare Diseases (ORD)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Cholangitis, Sclerosing
		Liver Cirrhosis, Biliary

2	Additional conditions recognized in this trial
		Cholangitis
		Fibrosis
		Liver Cirrhosis

3	More general conditions related to this trial
		Bile Duct Diseases
		Biliary Tract Diseases
		Cholestasis
		Cholestasis, Intrahepatic
		Digestive System Diseases
		Liver Diseases
		Pathologic Processes

4	Interventions listed in this trial
		budesonide

5	More general drug interventions related to this trial
		Anti-Asthmatic Agents
		Anti-Inflammatory Agents
		Autonomic Agents
		Bronchodilator Agents
		Glucocorticoids
		Hormones
		Hormones, Hormone Substitutes, and Hormone Antagonists
		Peripheral Nervous System Agents
		Pharmacologic Actions
		Physiological Effects of Drugs
		Respiratory System Agents
		Therapeutic Uses

6	Sponsors listed in this trial
		National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
		Mayo Clinic